Fasting Plasma Glucose (FPG)
Zinc supplementation → Fasting Plasma Glucose (FPG)
Zinc supplementation → Fasting Plasma Glucose (FPG)
Evidence profile
Key finding
The mean FBG in the intervention group decreased by 21.52 mg/dL.
This study examined the effects of zinc supplementation on glycemic control and lipid profiles in newly diagnosed type 2 diabetes patients, finding significant reductions in fasting plasma glucose and cholesterol levels.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Zinc supplementation, Placebo
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Primary outcome
Fasting Plasma Glucose (FPG)
Comparator
Placebo Group
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
This study examined the effects of zinc supplementation on glycemic control and lipid profiles in newly diagnosed type 2 diabetes patients, finding significant reductions in fasting plasma glucose and cholesterol levels.
These findings suggest that zinc supplementation could be a beneficial adjunct therapy for managing glycemic control and lipid profiles in patients with newly diagnosed type 2 diabetes. Improved management of these parameters is crucial for reducing the risk of complications associated with diabetes, such as cardiovascular disease.
The study did not assess long-term effects of zinc supplementation. Sample size and demographic diversity may limit generalizability. No significant changes were observed in HDL, VLDL, or ESR.
Published in
Publication details and source links for this paper.
Alexander M, John RA, Gurpreet SC, et al. The Impact of Zinc Supplementation on Glycemic Control and Lipid Profiles in Newly Diagnosed Type 2 Diabetes Patients. Cureus. 2024;16(9):e69180. doi:10.7759/cureus.69180
Save this study and add notes to your research library.
Fasting Plasma Glucose decreased by 21.52 mg/dL
Postprandial blood glucose decreased by 47.53 mg/dL
LDL cholesterol decreased by 25.06 mg/dL
Triglycerides decreased by 22.2 mg/dL
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Zinc supplementation and Fasting Plasma Glucose (FPG), Glucose iAUC (OGTT), HbA1c, and 3 more.
This study contributes evidence to
Primary intervention
Zinc supplementation
Primary outcomes
Evidence topics
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
2
Related topics
6
Evidence pairs
270
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Zinc supplementation → Fasting Plasma Glucose (FPG)
Zinc supplementation → Fasting Plasma Glucose (FPG)
Evidence profile
Zinc supplementation → Glucose iAUC (OGTT)
Zinc supplementation → Glucose iAUC (OGTT)
Evidence profile
Zinc supplementation → HbA1c
Zinc supplementation → HbA1c
Evidence profile
Zinc supplementation → LDL cholesterol
Zinc supplementation → LDL cholesterol
Evidence profile
Zinc supplementation → Total cholesterol
Zinc supplementation → Total cholesterol
Evidence profile
Zinc supplementation → Triglycerides
Zinc supplementation → Triglycerides
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Zinc supplementation and Fasting Glucose, Zinc supplementation and Postprandial and OGTT Glucose.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies measuring Adipokine and Angiogenic Markers
Measures Adipokine and Angiogenic Markers as a key outcome.
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
All studies measuring Postprandial and OGTT Glucose
Measures Postprandial and OGTT Glucose as a key outcome.
All studies on Zinc supplementation
Contributes to Zinc supplementation evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Zinc supplementation appears to improve Fasting Plasma Glucose (FPG).
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Zinc supplementation appears to improve Glucose iAUC (OGTT).
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Glucose iAUC (OGTT)
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Zinc supplementation appears to improve HbA1c.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Zinc supplementation appears to improve LDL cholesterol.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
LDL cholesterol
EvidenceScore™ Emerging | EvidenceScore™ 52.9 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Follow the topics this study contributes to.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.